KEMPHARM INC - NOTE 5.500% 2/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2017 to Q1 2020

Type / Class
Debt / NOTE 5.500% 2/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of KEMPHARM INC - NOTE 5.500% 2/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2020 Q1 $0 $0 -$1,230,000 0
2019 Q4 $3,000,000 $1,230,000 -$35,652,000 41.0% 1
2019 Q3 $73,673,000 $36,915,000 -$1,938,497 42.1% 3
2019 Q2 $76,673,000 $36,892,000 -$250,000 46.85% 3
2019 Q1 $76,673,000 $34,288,000 49.87% 3
2018 Q4 $76,673,000 $44,976,000 -$5,762,185 50.3% 3
2018 Q3 $86,250,000 $55,045,000 60.3% 3
2018 Q2 $86,250,000 $63,020,000 67.6% 3
2018 Q1 $86,250,000 $65,427,000 74.08% 3
2017 Q4 $86,250,000 $52,964,000 61.7% 3
2017 Q3 $86,250,000 $52,877,000 60.92% 3
2017 Q2 $86,250,000 $51,598,000 +$7,348,000 62.07% 3
2017 Q1 $75,000,000 $45,719,000 +$45,719,000 60.96% 1